Early transcatheter arterial embolization in duodenal ulcer bleeding following successful endoscopic hemostasis treatment

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-11001523

Enrollment

Unknown

Registered

2011-05-14

Start date

2008-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duodenal ulcer bleeding

Interventions

intervention group:endovascular embolization

control group:conservative medical treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Duodenal ulcer bleeding patients following successful initial endoscopic hemostasis have a high risk of bleeding

Exclusion criteria

Exclusion criteria: Patients with incomplete data; Pregnant and lactating women; Younger than 18 years of age; Chronic renal failure, creatinine> 300umol/L were

Design outcomes

Primary

Measure	Time frame
To bleed again to intervention treatment rates;30 days rebleeding rate;1 week rebleeding rate;30 days mortality rate;	—

Secondary

Measure	Time frame
amount of blood transfusion;average length of hospital stay;	—

Countries

China

Contacts

Public ContactXiao Li

simonlixiao@263.net+86 18980601291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026